ClinicalTrials.Veeva

Menu

Investigation of Respiratory-related Tumour Motion in Liver Cancer Patients Undergoing SBRT Using Audiovisual Biofeedback (LAVA)

U

University of Sydney

Status

Completed

Conditions

Lung Cancer

Treatments

Device: Breathe Well

Study type

Interventional

Funder types

Other

Identifiers

NCT04323618
LAVA V4

Details and patient eligibility

About

Investigation of respiratory-related tumour motion in liver cancer patients undergoing stereotactic body radiotherapy treatment (SBRT) using audiovisual (AV) biofeedback.

Enrollment

5 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Liver cancer patients, either primary hepatocellular carcinoma or liver metastases, eligible for stereotactic radiotherapy.
  • >18 years old
  • Radio-opaque markers implanted (fiducials and/or surgical clips previously implanted in the liver)
  • Able to give written informed consent and willingness to participate and comply with the study

Exclusion criteria

  • Pregnant / lactating women

Trial design

Primary purpose

Device Feasibility

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

5 participants in 1 patient group

Free breathing or Breathe Well
Other group
Description:
Free breathing or Breathe Well
Treatment:
Device: Breathe Well

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems